Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro

Biomaterials

Volumn 23, Issue 23, 2002, Pages 4573-4579

  Kawamata, Yosei ^a   Nagayama, Yuji ^b   Nakao, Kazuhiko ^a   Mizuguchi, Hiroyuki ^c   Hayakawa, Takao ^c   Sato, Toshinori ^d   Ishii, Nobuko ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d KEIO UNIVERSITY   (Japan)

Author keywords

Adenovirus; Chitosan; CHO cells; Gene transfer; Integrin

Indexed keywords

BIOCOMPATIBILITY; CATIONIC POLYMERIZATION; CELLS; CONCENTRATION (PROCESS); MOLECULAR WEIGHT;

RECEPTOR-INDEPENDENT AUGMENTATION;

GENE TRANSFER;

ADENOVIRUS VECTOR; ALPHA5 INTEGRIN; BETA GALACTOSIDASE; BETA3 INTEGRIN; CHITOSAN; GLUCOSAMINE; N ACETYLGLUCOSAMINE;

ANIMAL CELL; ARTICLE; ASSAY; BINDING SITE; CHO CELL; CONTROLLED STUDY; CULTURE MEDIUM; GENE TRANSFER; IN VITRO STUDY; INFECTION SENSITIVITY; MAMMAL CELL; MOLECULAR WEIGHT; NONHUMAN; OVARY CELL; PH; PRIORITY JOURNAL; PROTEIN BINDING; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION; WILD TYPE;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; BIOCOMPATIBLE MATERIALS; BIOPOLYMERS; CATIONS; CHITIN; CHITOSAN; CHO CELLS; CRICETINAE; GENE TRANSFER TECHNIQUES; HYDROGEN-ION CONCENTRATION; INTEGRINS; LIPID METABOLISM; OLIGOPEPTIDES; POLYSACCHARIDES; TIME FACTORS;

ADENOVIRIDAE; CRICETINAE; CRICETULUS GRISEUS; MAMMALIA;

EID: 0346003766     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(02)00203-X     Document Type: Article

References (32)

1. Roth J.A., Cristiano R.J. Gene therapy for cancer. What have we done and where are we going? J Nat Cancer Inst. 89:1997;21-39.
2. Yanez R.J., Porter A.C.G. Therapeutic gene targeting. Gene Ther. 5:1998;149-159.
3. Zhang W.-W. Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther. 6:1999;113-138.
4. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., Finberg R.W. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science. 275:1997;1320-1323.
5. Arcasoy S.M., Latoche J.D., Gondor M., Pitt B.R., Pilewski J.M. Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro. Gene Ther. 4:1997;32-38.
6. Baker A., Saltik M., Lehrmann H., Killisch I., Mautner V., Lamm G., Christofori G., Cotten M. Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther. 4:1997;773-782.
7. Fasbender A., Zabner J., Chillon M., Moninger T.O., Puga A.P., Davidson B.L., Welsh M.J. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem. 272:1997;6479-6489.
8. Byk T., Haddada H., Vainchenker W., Louache F. Lipofectamine and related cationic lipids strongly improve adenoviral infection efficiency of primitive human hematopoietic cells. Hum Gene Ther. 9:1998;2493-2502.
9. Chillon M., Lee J.H., Fasbender A., Welsh M.J. Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Ther. 5:1998;995-1002.
10. Dietz A.B., Vuk-Pavlovic S. High efficiency adenovirus- mediated gene transfer to human dendritic cells. Blood. 91:1998;392-398.
11. Kaplan J.M., Pennington S.E., St. George J.A., Woodworth L.A., Fasbender A.L., Marshall J., Cheng S.H., Wadsworth S.C., Gregory R.J., Smith A.E. Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Hum Gene Ther. 9:1998;1469-1479.
12. Qiu C., De Young M.B., Finn A., Dichek D.A. Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins. Hum Gene Ther. 9:1998;507-520.
13. Clark P.R., Stopeck A.T., Brailey J.L., Wang Q., McArthur J., Finer M.H., Hersh E.M. Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells. Cancer Gene Ther. 6:1999;437-446.
14. Di Nicola M., Milanesi M., Magni M., Bregni M., Carlo-Stella C., Longoni P., Tomanin R., Ravagnani F., Scarpa M., Jordan C., Gianni M. Recombinant adenoviral vector-lipofectAMINE complex for gene transduction into human T lymphocytes. Hum Gene Ther. 10:1999;1875-1884.
15. Varum K.M., Myhr M.M., Hjerde R.J., Smidsrod O. In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr Res. 299:1997;99-101.
16. Sato T., Ishii T., Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials. 22:2001;2075-2080.
17. Ishii T., Okahata Y., Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim Biophys Acta. 1514:2001;51-64.
18. Borchard G. Chitosans for gene therapy. Adv Drug Delivery Rev. 52:2001;145-150.
19. Erbacher P., Zou S., Bettinger T., Steffan A.M., Remy J.S. Chitosan-based vector/DNA complexes for gene delivery. biophysical characteristics and transfection ability Pharm Res. 15:1998;1332-1339.
20. Lee K.Y., Kwon I.C., Kim Y.H., Jo W.H., Jeong S.Y. Preparation of chitosan self-aggregates as a gene delivery system. J Control Release. 51:1998;213-220.
21. Leong K.W., Mao H.Q., Truong-Le V.L., Roy K., Walsh S.M., August J.T. DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release. 53:1998;183-193.
22. MacLaughlin F.C., Mumper R.J., Wang J., Tagliaferri J.M., Gill I., Hinchcliffe M., Rolland A.P. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release. 56:1998;259-272.
23. Richardson S.C., Kolbe H.V., Duncan R. Potential of low molecular mass chitosan as a DNA delivery system. biocompatibility, body distribution and ability to complex and protect DNA Int J Pharm. 178:1999;231-243.
24. Roy K., Mao H.Q., Huang S.-K., Leong K.W. Oral gene delivery with chitosan- DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med. 5:1999;387-391.
25. Koping-Hoggard M., Tubulekas I., Guan H., Edwards K., Nilsson M., Varum K.M., Artursson P. Chitosan as a nonviral delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. 8:2001;1108-1121.
26. Croyle M.A., Cheng X., Sandhu A., Wilson J.M. Development of novel formulations that enhance adenoviral-mediated gene expression in the lung in vitro and in vivo. Mol Ther. 4:2001;22-28.
27. Nagayama Y., Yokoi H., Takeda K., Hasegawa M., Nishihara E., Namba H., Yamashina S., Niwa M. Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo. J Clin Endocrinol Metab. 85:2000;4081-4086.
28. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-200.
29. Okada N., Tsukada Y., Nakagawa S., Mizuguchi H., Mori K., Saito T., Fujita T., Yamamoto A., Hayakawa T., Mayumi T. Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors. Biochem Biophys Res Commun. 282:2001;173-179.
30. Nagayama Y., Nishihara E., Namba H., Yokoi H., Hasegawa M., Mizuguchi H., Hayakawa T., Yamashita S., Niwa M. Targeting the replication of adenovirus to p53-defective thyroid carcinoma with a p53-regulated Cre-loxP system. Cancer Gene Ther. 8:2001;36-44.
31. Walters R., Welsh M. Mechanism by which calcium phosphate coprecipitation enhances adenovirus-mediated gene transfer. Gene Ther. 6:1999;1845-1850.
32. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res. 15:1998;1326-1331.